These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 8817827
1. Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin. Ruedl C, Rieser C, Kofler N, Wick G, Wolf H. Vaccine; 1996 Jun; 14(8):792-8. PubMed ID: 8817827 [Abstract] [Full Text] [Related]
2. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb. Martin M, Metzger DJ, Michalek SM, Connell TD, Russell MW. Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399 [Abstract] [Full Text] [Related]
3. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge. Beignon AS, Briand JP, Muller S, Partidos CD. Immunology; 2001 Mar; 102(3):344-51. PubMed ID: 11298834 [Abstract] [Full Text] [Related]
4. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit. Boyaka PN, Ohmura M, Fujihashi K, Koga T, Yamamoto M, Kweon MN, Takeda Y, Jackson RJ, Kiyono H, Yuki Y, McGhee JR. J Immunol; 2003 Jan 01; 170(1):454-62. PubMed ID: 12496431 [Abstract] [Full Text] [Related]
9. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant. Rask C, Fredriksson M, Lindblad M, Czerkinsky C, Holmgren J. APMIS; 2000 Mar 01; 108(3):178-86. PubMed ID: 10752686 [Abstract] [Full Text] [Related]
10. Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine. Lu X, Clements JD, Katz JM. Vaccine; 2002 Jan 15; 20(7-8):1019-29. PubMed ID: 11803061 [Abstract] [Full Text] [Related]
11. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen. Verweij WR, de Haan L, Holtrop M, Agsteribbe E, Brands R, van Scharrenburg GJ, Wilschut J. Vaccine; 1998 Dec 15; 16(20):2069-76. PubMed ID: 9796066 [Abstract] [Full Text] [Related]
12. Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches. Nakagawa I, Takahashi I, Kiyono H, McGhee JR, Hamada S. J Infect Dis; 1996 Jun 15; 173(6):1428-36. PubMed ID: 8648216 [Abstract] [Full Text] [Related]
13. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes. Park EJ, Chang JH, Kim JS, Yum JS, Chung SI. Exp Mol Med; 2000 Jun 30; 32(2):72-8. PubMed ID: 10926118 [Abstract] [Full Text] [Related]
14. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution. McCluskie MJ, Weeratna RD, Davis HL. Mol Med; 2000 Oct 30; 6(10):867-77. PubMed ID: 11126201 [Abstract] [Full Text] [Related]
15. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells. Martin M, Hajishengallis G, Metzger DJ, Michalek SM, Connell TD, Russell MW. Infect Immun; 2001 Jan 30; 69(1):252-61. PubMed ID: 11119513 [Abstract] [Full Text] [Related]
17. Modulation of the humoral and cellular immune response in Abeta immunotherapy by the adjuvants monophosphoryl lipid A (MPL), cholera toxin B subunit (CTB) and E. coli enterotoxin LT(R192G). Maier M, Seabrook TJ, Lemere CA. Vaccine; 2005 Oct 25; 23(44):5149-59. PubMed ID: 16054274 [Abstract] [Full Text] [Related]
18. Fusion-expressed CtxB-TcpA-C-CPE improves both systemic and mucosal humoral and T-cell responses against cholera in mice. Souod N, Kargar M, Hoseini MH, Jafarinia M. Microb Pathog; 2021 Aug 25; 157():104978. PubMed ID: 34022352 [Abstract] [Full Text] [Related]
19. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections. Jakobsen H, Schulz D, Pizza M, Rappuoli R, Jónsdóttir I. Infect Immun; 1999 Nov 25; 67(11):5892-7. PubMed ID: 10531245 [Abstract] [Full Text] [Related]
20. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation. Byrd W, Boedeker EC. Vet Immunol Immunopathol; 2013 Mar 15; 152(1-2):57-67. PubMed ID: 23122616 [Abstract] [Full Text] [Related] Page: [Next] [New Search]